2023
Understanding Heterogeneity in Patients’ Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis
Hsiao B, Downs J, Lanyon M, Blalock S, Curtis J, Harrold L, Nowell W, Wiedmeyer C, Venkatachalam S, Patterson M, Gavigan K, Stradford L, Ali D, Fraenkel L. Understanding Heterogeneity in Patients’ Conceptualisation of Treatment for Rheumatoid Arthritis: A Cluster Analysis. BMJ Open 2023, 13: e070848. PMID: 37666546, PMCID: PMC10481841, DOI: 10.1136/bmjopen-2022-070848.Peer-Reviewed Original ResearchConceptsDisease-modifying antirheumatic drugsMedication adherencePatients' conceptualisationRA treatmentRisk/benefit ratioEffective patient-physician communicationFull medication adherenceRheumatoid arthritis managementPatient-physician communicationLower decisional conflictHigh-quality careOnly significant demographic predictorPatient hesitancyAntirheumatic drugsDisease activityPhysician recommendationArthritis managementRheumatoid arthritisSignificant demographic predictorsEligible participantsPatient interviewsResearch RegistryTreatment variesDecisional conflictQuality care
2022
AB1584-PARE UNDERSTANDING HETEROGENEITY IN PATIENTS’ CONCEPTUALIZATION OF TREATMENT FOR RHEUMATOID ARTHRITIS: A CLUSTER ANALYSIS
Hsiao B, Downs J, Lanyon M, Curtis J, Blalock S, Wiedmeyer C, Venkatachalam S, Nowell W, Fraenkel L. AB1584-PARE UNDERSTANDING HETEROGENEITY IN PATIENTS’ CONCEPTUALIZATION OF TREATMENT FOR RHEUMATOID ARTHRITIS: A CLUSTER ANALYSIS. Annals Of The Rheumatic Diseases 2022, 81: 1890.2-1891. DOI: 10.1136/annrheumdis-2022-eular.2964.Peer-Reviewed Original ResearchRisk/benefit ratioRheumatoid arthritisGrant/research supportHigh-quality careDisease activityQuality careMean scoreBenefit ratioSystem-related barriersDepth patient interviewsCare/supportEli LillyQuality of careNon-Hispanic whitesRisk/benefitRatings of accessConceptualization of treatmentPhysician-patient relationshipTreatment escalationAntirheumatic drugsConclusions PatientsPoor adherenceSuboptimal carePatient interviewsDMARDs